JP Morgan Chase
VMD icon

JP Morgan Chase’s Viemed Healthcare VMD Stock Holding History

JP Morgan Chase’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
111,162
-3,181
-3% -$31.5K ﹤0.01% 4513
2026
Q1 		$1.07M Sell
114,343
-40,498
-26% -$337K ﹤0.01% 4569
2025
Q4 		$1.15M Buy
154,841
+4,921
+3% +$33.7K ﹤0.01% 4508
2025
Q3 		$1.02M Sell
149,920
-24,631
-14% -$167K ﹤0.01% 4579
2025
Q2 		$1.21M Buy
174,551
+5,099
+3% +$34.6K ﹤0.01% 4261
2025
Q1 		$1.23M Sell
169,452
-59,200
-26% -$465K ﹤0.01% 4207
2024
Q4 		$1.83M Buy
228,652
+129,854
+131% +$1.13M ﹤0.01% 4218
2024
Q3 		$724K Buy
98,798
+59,538
+152% +$425K ﹤0.01% 4676
2024
Q2 		$257K Buy
39,260
+11,381
+41% +$85.8K ﹤0.01% 5022
2024
Q1 		$263K Buy
27,879
+5,147
+23% +$44.1K ﹤0.01% 5194
2023
Q4 		$178K Sell
22,732
-587
-3% -$4.26K ﹤0.01% 5446
2023
Q3 		$157K Sell
23,319
-3,302
-12% -$27.1K ﹤0.01% 5213
2023
Q2 		$260K Sell
26,621
-29,371
-52% -$298K ﹤0.01% 4919
2023
Q1 		$540K Buy
55,992
+55,841
+36,981% +$487K ﹤0.01% 4448
2022
Q4 		$1K Hold
151
– – ﹤0.01% 6450
2022
Q3 		$1K Sell
151
-1,490
-91% -$9.56K ﹤0.01% 6378
2022
Q2 		$9K Sell
1,641
-19,633
-92% -$106K ﹤0.01% 6056
2022
Q1 		$107K Sell
21,274
-29,432
-58% -$137K ﹤0.01% 5474
2021
Q4 		$265K Sell
50,706
-34,435
-40% -$192K ﹤0.01% 5194
2021
Q3 		$472K Sell
85,141
-54,571
-39% -$355K ﹤0.01% 4769
2021
Q2 		$998K Buy
139,712
+19,383
+16% +$168K ﹤0.01% 4294
2021
Q1 		$1.22M Sell
120,329
-86,782
-42% -$817K ﹤0.01% 4088
2020
Q4 		$1.61M Buy
207,111
+14,053
+7% +$124K ﹤0.01% 3642
2020
Q3 		$1.75M Buy
193,058
+121,504
+170% +$1.23M ﹤0.01% 3327
2020
Q2 		$687K Buy
+71,554
New +$556K ﹤0.01% 3715
2020
Q1 		– Sell
-126,200
Closed -$782K – 5756
2019
Q4 		$782K Sell
126,200
-62,100
-33% -$430K ﹤0.01% 4004
2019
Q3 		$1.44M Buy
+188,300
New +$1.25M ﹤0.01% 3623

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

JP Morgan Chase's VMD Position: Q2 2026 in Review

JP Morgan Chase reduced its Viemed Healthcare (VMD) stake by 2.8% in Q2 2026, selling an estimated $31.5K and leaving 111,162 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #4513.

JP Morgan Chase first reported a position in VMD in Q3 2019 and has held it in 27 quarters since. The position peaked at $1.83M in Q4 2024. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • JP Morgan Chase held 111,162 shares of Viemed Healthcare worth $1.27M as of Q2 2026.
  • JP Morgan Chase sold 3,181 Viemed Healthcare shares in Q2 2026, an estimated $31.5K.
  • Viemed Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4513 holding.
  • JP Morgan Chase first reported a position in Viemed Healthcare in Q3 2019 and has held it in 27 quarters since.
  • JP Morgan Chase's Viemed Healthcare position peaked at $1.83M in Q4 2024.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.